CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
REVENUES
Patient fee revenue – net of contractual allowances and discounts	$ 8,614	$ 8,188	$ 25,511	$ 21,393
Product sales – net	110	25	329	225
Service and repair fees – net	1,818	1,831	5,460	5,489
Service and repair fees - related parties – net	39	28	94	83
Management and other fees – net	12,149	12,375	36,585	36,717
Management and other fees - related medical practices – net	2,988	2,975	8,962	8,962
Total Revenues – Net	25,718	25,422	76,941	72,869
COSTS AND EXPENSES
Costs related to patient fee revenue	4,437	4,056	13,466	11,879
Costs related to product sales	153	196	558	580
Costs related to service and repair fees	900	801	2,533	2,241
Costs related to service and repair fees - related parties	82	12	106	34
Costs related to management and other fees	6,864	7,157	21,095	20,281
Costs related to management and other fees – related medical practices	1,529	1,455	4,638	4,345
Research and development	414	435	1,297	1,126
Selling, general and administrative	7,593	7,143	18,046	20,074
Total Costs and Expenses	21,972	21,255	61,739	60,560
Income From Operations	3,746	4,167	15,202	12,309
Other Income (Expense)	45	(6)	46	(203)
Other Income – related party	(0)		577	0
Interest Expense	(9)	(15)	(67)	(41)
Investment Income – related party	13	0	13	0
Investment Income	536	356	1,576	770
Income Before Provision for Income Taxes and Non controlling Interests	4,331	4,502	17,347	12,835
Provision for Income Taxes	(1,848)	(17)	(4,884)	(2,889)
Net Income	2,483	4,485	12,463	9,946
Net Income – Non controlling Interests	(611)	(625)	(2,726)	(1,807)
Net Income – Attributable to FONAR	$ 1,872	$ 3,860	$ 9,737	$ 8,139